{"@context":"https://schema.org","@type":"Corporation","name":"BETA DRUGS LIMITED","alternateName":"BETA","tickerSymbol":"BETA","identifier":"BETA","description":"BETA DRUGS LIMITED (BETA) financials: Market Cap ₹1,906Cr., Price ₹1,720, P/E 119, ROE 10.3%. Jun 2026: sales ₹55.83 Cr, net profit ₹5.93 Cr. Quarterly results…","url":"https://fincrux.org/companies/BETA","sameAs":["https://fincrux.org/companies/BETA"],"dateModified":"2026-10-20T06:46:17.722493","additionalProperty":[{"@type":"PropertyValue","name":"Market Cap","value":"₹1,906Cr."},{"@type":"PropertyValue","name":"Current Price","value":"₹1,720"},{"@type":"PropertyValue","name":"Stock P/E","value":"119"},{"@type":"PropertyValue","name":"ROE","value":"10.3%"},{"@type":"PropertyValue","name":"ROCE","value":"11.2%"},{"@type":"PropertyValue","name":"Book Value","value":"₹148"},{"@type":"PropertyValue","name":"Dividend Yield","value":"0.00%"},{"@type":"PropertyValue","name":"52W High / Low","value":"₹2,808/990"}],"mainEntityOfPage":{"@type":"WebPage","@id":"https://fincrux.org/companies/BETA#webpage","name":"BETA DRUGS LIMITED (BETA) Financials, Quarterly Results & Ratios","url":"https://fincrux.org/companies/BETA","isPartOf":{"@id":"https://fincrux.org/#website"}},"publisher":{"@type":"Organization","name":"Fincrux","url":"https://fincrux.org"},"potentialAction":{"@type":"ViewAction","target":"https://fincrux.org/companies/BETA"}}